Related Experiment Video

Updated: Jan 19, 2026

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.8K

Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis

Yao Ma1, Xiao-Fei Feng2,3, Wan-Xia Yang1

  • 1Laboratory Medicine Center, Lanzhou University Second Hospital, Lanzhou 730030, China.

Biomed Research International
|September 20, 2019
PubMed

Insights

This study explores bladder cancer's genomic and immune landscape using TCGA data. It identifies key genes and immune cell changes to discover new therapeutic targets for improved bladder cancer treatment.

Area of Science:

  • Oncology
  • Genomics
  • Immunotherapy

Background:

  • Immunotherapy has advanced bladder cancer treatment, but poor prognosis persists for some patients.
  • Discovering novel therapeutic targets is crucial for improving bladder cancer outcomes.
  • High-throughput sequencing and tumor profiling have identified potential tumor biomarkers.

Purpose of the Study:

  • To identify key genes driving urinary bladder neoplasm development and prognosis using TCGA data.
  • To investigate the relationship between tumor mutation burden and the immune microenvironment in bladder cancer.
  • To provide new therapeutic strategies for bladder cancer based on genomic and immune insights.

Main Methods:

  • Analysis of data from The Cancer Genome Atlas (TCGA) database.
  • Interpretation of genomic data to identify key genes in urinary bladder neoplasm.
  • Assessment of the correlation between tumor mutation burden and immune cell infiltration.

Main Results:

  • Identification of specific genes implicated in bladder cancer development and prognosis.
  • Characterization of the bladder cancer immune microenvironment and associated immune cell alterations.
  • Establishment of a link between tumor mutation burden and immune cell dynamics.

Conclusions:

  • Genomic and immune profiling reveals critical factors influencing bladder cancer.
  • Understanding these factors can guide the development of novel immunotherapies.
  • This research paves the way for improved therapeutic interventions for bladder cancer patients.

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.0K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.7K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.3K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K